Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

XBITV - XBiotech Inc TEMP

Previous close
14.62
14.620   100.000%

Share volume: 0
Last Updated: Wed 19 Feb 2020 10:00:00 PM CET
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
59%
Profitability 75%
Dept financing 25%
Liquidity 0%
Performance 65%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$14.62
P/E Ratio 
N/A
DAY RANGE
$14.62 - $14.62
EPS 
$0.00
52 WEEK RANGE
$0.00 - $14.62
52 WEEK CHANGE
$0.00
MARKET CAP 
619.381 M
YIELD 
N/A
SHARES OUTSTANDING 
42.365 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: John Simard
Region: US
Website: http://www.xbiotech.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

XBiotech, Inc. is a biopharmaceutical company. The firm engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

Recent news